期刊文献+

中药济生散配合唑来膦酸治疗恶性肿瘤骨转移的临床观察 被引量:7

下载PDF
导出
摘要 目的:观察中药济生散联合唑来膦酸治疗恶性肿瘤骨转移的临床疗效。方法:将恶性肿瘤骨转移患者48例随机分为联合治疗组和唑来膦酸组,两组均采用唑来膦酸治疗,联合治疗组加用中药济生散口服。结果:联合治疗组镇痛有效率高于唑来膦酸组;生活质量改善优于唑来膦酸组。结论:中药济生散联合唑来膦酸联合应用疗效显著。
作者 缪娴 顾小侠
出处 《四川中医》 2013年第8期78-80,共3页 Journal of Sichuan of Traditional Chinese Medicine
  • 相关文献

参考文献5

  • 1Seiji Matsumoto,Shinya Kimura,Hidekazu Segawa,Junya Kuroda,Takeshi Yuasa,Kiyoshi Sato,Masaki Nogawa,Fumihiro Tanaka,Taira Maekawa,Hiromi Wada.Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell lines[J].Lung Cancer.2004(1)
  • 2Andrej Skerjanec,James Berenson,Chyi Hung Hsu,Pierre Major,Wilson H. Miller,Christina Raveray,Horst Schran,John Seaman,Felix Waldmeier.The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function[J].The Journal of Clinical Pharmacology.2003(2)
  • 3Gregory R Mundy,Toshiyuki Yoneda,Toru Hiraga.Preclinical studies with zoledronic acid and other bisphosphonates: Impact on the bone microenvironment[J].Seminars in Oncology.2001
  • 4Zhi-Ling Zhang,Yong-Hong Li,Jun-Hang Luo,Zhuo-Wei Liu,Kai Yao,Pei Dong,Hui Han,Zi-Ke Qin,Wei Chen,Fang-Jian Zhou.Complications of radical nephrectomy for renal cell carcinoma: a retrospective study comparing transperitoneal and retroperitoneal approaches using a standardized reporting methodology in two Chinese centers[J].Chinese Journal of Cancer,2013,32(8):461-468. 被引量:3
  • 5King AE,Umland Em.Ostenonecrosis of the jaw in patients receiving intravenous of oral bisphosphonates[].Pharmaeo Theapy.2008

二级参考文献32

  • 1Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin, 1999,49:8-31, 31.
  • 2Pantuck A J, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol, 2001,166:1611-1623.
  • 3Filson CP, Banerjee M, Wolf JS Jr, et al. Surgeon characteristics and long-term trends in the adoption of laparoscopic radical nephrectomy. J Urol, 2011,185:2072-2077.
  • 4Cooperberg MR, Mallin K, Kane C J, et al. Treatment trends for stage I renal cell carcinoma. J Urol, 2011,186:394-399.
  • 5Kim SP, Shah ND, Weight CJ, et al. Contemporary trends in nephrectomy for renal cell carcinoma in the united states: results from a population based cohort. J Urol, 2011,186:1779-1785.
  • 6Stephenson A J, Hakimi AA, Snyder ME, et al. Complications of radical and partial nephrectomy in a large contemporary cohort. J Urol, 2004,171:130-134.
  • 7Shekarriz B, Upadhyay J, Shekarriz H, et al. Comparison of costs and complications of radical and partial nephrectomy for treatment of localized renal cell carcinoma. Urology, 2002,59:211-215.
  • 8Joudi FN, Allareddy V, Kane C J, et al. Analysis of complications following partial and total nephrectomy for renal cancer in a population based sample. J Urol, 2007,177:1709-1714.
  • 9Shuford MD, McDougall EM, Chang SS, et al. Complications of contemporary radical nephrectomy: comparison of open vs. laparoscopic approach. Urol Oncol, 2004,22:121-126.
  • 10Mejean A, Vogt B, Quazza JE, et al. Mortality and morbidity after nephrectomy for renal cell carcinoma using a transperitoneal anterior subcostal incision. Eur Urol, 1999,36:298-302.

共引文献2

同被引文献121

引证文献7

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部